Anthony T Fojo1, Natalie L Stennis2, Andrew S Azman3, Emily A Kendall4, Sourya Shrestha3, Shama D Ahuja2, David W Dowdy3. 1. Division of General Internal Medicine, Johns Hopkins University School of Medicine, 2024 Monument St., Baltimore, MD, USA 21205. 2. Bureau of Tuberculosis Control, New York City Department of Health and Mental Hygiene, 42-09 28th St, 21st floor, Long Island City, NY, USA 11101. 3. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe St. Room E6531, Baltimore, MD, USA 21205. 4. Division of Infectious Diseases, Johns Hopkins University School of Medicine, PCTB Suite 211, 725 N. Wolfe St., Baltimore, MD, USA 21205.
Abstract
BACKGROUND: After steady decline since the 1990s, tuberculosis (TB) incidence in New York City (NYC) and the United States (US) has flattened. The reasons for this trend and the implications for the future trajectory of TB in the US remain unclear. METHODS: We developed a compartmental model of TB in NYC, parameterized with detailed epidemiological data. We ran the model under five alternative scenarios representing different explanations for recent declines in TB incidence. We evaluated each scenario's relative likelihood by comparing its output to available data. We used the most likely scenarios to explore drivers of TB incidence and predict future trajectories of the TB epidemic in NYC. FINDINGS: Demographic changes and declining TB transmission alone were insufficient to explain recent trends in NYC TB incidence. Only scenarios that assumed contemporary changes in TB dynamics among the foreign-born - a declining rate of reactivation or a decrease in imported subclinical TB - could accurately describe the trajectory of TB incidence since 2007. In those scenarios, the projected decline in TB incidence from 2015 to 2025 varied from minimal [2·0%/year (95% credible interval 0·4-3·5%)] to similar to 2005 to 2009 trends [4·4%/year (2·5-6·4%)]. The primary factor differentiating optimistic from pessimistic projections was the degree to which improvements in TB dynamics among the foreign-born continued into the coming decade. INTERPRETATION: Further progress against TB in NYC requires additional focus on the foreign-born population. Absent additional intervention in this group, TB incidence may not decline further.
BACKGROUND: After steady decline since the 1990s, tuberculosis (TB) incidence in New York City (NYC) and the United States (US) has flattened. The reasons for this trend and the implications for the future trajectory of TB in the US remain unclear. METHODS: We developed a compartmental model of TB in NYC, parameterized with detailed epidemiological data. We ran the model under five alternative scenarios representing different explanations for recent declines in TB incidence. We evaluated each scenario's relative likelihood by comparing its output to available data. We used the most likely scenarios to explore drivers of TB incidence and predict future trajectories of the TB epidemic in NYC. FINDINGS: Demographic changes and declining TB transmission alone were insufficient to explain recent trends in NYC TB incidence. Only scenarios that assumed contemporary changes in TB dynamics among the foreign-born - a declining rate of reactivation or a decrease in imported subclinical TB - could accurately describe the trajectory of TB incidence since 2007. In those scenarios, the projected decline in TB incidence from 2015 to 2025 varied from minimal [2·0%/year (95% credible interval 0·4-3·5%)] to similar to 2005 to 2009 trends [4·4%/year (2·5-6·4%)]. The primary factor differentiating optimistic from pessimistic projections was the degree to which improvements in TB dynamics among the foreign-born continued into the coming decade. INTERPRETATION: Further progress against TB in NYC requires additional focus on the foreign-born population. Absent additional intervention in this group, TB incidence may not decline further.
Entities:
Keywords:
Health Resources; Humans; Mathematical Model; New York City; Tuberculosis; United States
Authors: den Bosch J H Wolleswinkel-van; N J D Nagelkerke; J F Broekmans; M W Borgdorff Journal: Int J Tuberc Lung Dis Date: 2002-02 Impact factor: 2.373
Authors: Carla M Clark; Cynthia R Driver; Sonal S Munsiff; Jeffrey R Driscoll; Barry N Kreiswirth; Benyang Zhao; Adeleh Ebrahimzadeh; Max Salfinger; Amy S Piatek; Jalaa Abdelwahab Journal: Emerg Infect Dis Date: 2006-05 Impact factor: 6.883
Authors: Kirsten Bibbins-Domingo; David C Grossman; Susan J Curry; Linda Bauman; Karina W Davidson; John W Epling; Francisco A R García; Jessica Herzstein; Alex R Kemper; Alex H Krist; Ann E Kurth; C Seth Landefeld; Carol M Mangione; William R Phillips; Maureen G Phipps; Michael P Pignone Journal: JAMA Date: 2016-09-06 Impact factor: 56.272
Authors: Lisa A Ronald; Jonathon R Campbell; Caren Rose; Robert Balshaw; Kamila Romanowski; David Z Roth; Fawziah Marra; Kevin Schwartzman; Victoria J Cook; James C Johnston Journal: Clin Infect Dis Date: 2019-11-27 Impact factor: 9.079
Authors: Sourya Shrestha; Sarah Cherng; Andrew N Hill; Sue Reynolds; Jennifer Flood; Pennan M Barry; Adam Readhead; Margaret Oxtoby; Michael Lauzardo; Tom Privett; Suzanne M Marks; David W Dowdy Journal: Am J Epidemiol Date: 2019-09-01 Impact factor: 4.897
Authors: Beate Kampmann; James A Seddon; James Paton; Zohreh Nademi; Denis Keane; Bhanu Williams; Amanda Williams; Sue Liebeschutz; Anna Riddell; Jolanta Bernatoniene; Sanjay Patel; Nuria Martinez; Paddy McMaster; Robindra Basu-Roy; Steven B Welch Journal: Am J Respir Crit Care Med Date: 2018-04-15 Impact factor: 21.405
Authors: Nicolas A Menzies; Andrea Parriott; Sourya Shrestha; David W Dowdy; Ted Cohen; Joshua A Salomon; Suzanne M Marks; Andrew N Hill; Carla A Winston; Garrett R Asay; Pennan Barry; Adam Readhead; Jennifer Flood; James G Kahn; Priya B Shete Journal: Am J Respir Crit Care Med Date: 2020-02-01 Impact factor: 21.405